The International Journal of Pharmaceutical, Biological and Chemical Sciences (IJPBCS) e-ISSN: 2278 - 5191 is committed to upholding the highest standards of publication ethics, integrity, and transparency, following the guidelines established by the Committee on Publication Ethics (COPE). The journal ensures a fair and rigorous peer-review process, ethical research practices, and unrestricted access to scientific knowledge.

  1. Peer Review Process
  • The journal follows a double-blind peer review process to ensure objectivity and fairness.
  • Manuscripts are reviewed by at least two independent experts in the field.
  • Reviewers and authors remain anonymous to each other to prevent bias.
  • The final decision on publication rests with the Editor-in-Chief, based on reviewers’ recommendations and compliance with journal guidelines.
  1. Authorship and Contribution
  • Authors must meet the criteria established by the ICMJE (International Committee of Medical Journal Editors), which include:
    • Substantial contributions to the study conception, design, data collection, or analysis.
    • Drafting or critically revising the manuscript.
    • Final approval of the version to be published.
    • Agreement to be accountable for all aspects of the work.
  • All authors must disclose their specific contributions in the manuscript.
  • Ghostwriting, guest authorship, or honorary authorship is strictly prohibited.
  1. Ethical Considerations in Research
  • Authors must comply with ethical guidelines, including:
    • Human and animal research: Studies involving human subjects must have approval from an Institutional Ethics Committee (IEC) and comply with the Declaration of Helsinki. Animal studies must follow guidelines from relevant regulatory bodies.
    • Informed consent: Authors must obtain written informed consent from human participants before conducting research.
    • Clinical trials: Must be registered in a publicly accessible trial registry (e.g., ClinicalTrials.gov).
  1. Plagiarism and Academic Misconduct
  • The journal strictly prohibits plagiarism, fabrication, falsification, and redundant publication.
  • All submissions are checked for plagiarism using reliable plagiarism detection software.
  • If plagiarism is detected, the manuscript will be rejected, and appropriate actions will be taken following COPE guidelines.
  1. Conflicts of Interest
  • Authors, reviewers, and editors must disclose any financial, institutional, or personal conflicts of interest that may influence the research or review process.
  • If conflicts of interest are found post-publication, corrective measures such as retractions or corrections may be taken.
  1. Data Availability and Transparency
  • Authors should provide raw data, protocols, and supplementary materials upon request.
  • Research data must be accurately reported, reproducible, and free from manipulation.
  1. Retractions, Corrections, and Expressions of Concern
  • The journal follows COPE guidelines for handling erroneous or unethical publications:
    • Corrections: Minor errors that do not affect the study's conclusions will be corrected through an erratum or corrigendum.
    • Retractions: If a study is found to have serious ethical violations, fabrication, or falsification, it will be retracted with a formal statement explaining the reasons.
    • Expressions of Concern: If there are unresolved ethical issues under investigation, a statement will be published until a final decision is reached.
  1. Copyright and Open Access Policy
  • The journal follows an open-access model, ensuring that all published content is freely available under the Creative Commons Attribution-NonCommercial-ShareAlike(CC-BY-NC-SA) License.
  • Authors retain copyright but grant the journal the right to publish, distribute, and archive the manuscript.
  1. Appeals and Complaints
  • Authors who believe their manuscript was unfairly rejected may submit a formal appeal, providing clear justifications.
  • Complaints about ethical breaches or editorial decisions should be addressed to the Editor-in-Chief, who will investigate following COPE’s dispute resolution guidelines.

By submitting to IJPBCS, authors agree to adhere to these editorial policies and maintain the highest ethical standards in scientific publishing.